![Mark Storey: From asymptomatic to oligo, we remain a critical component of treatment](https://oncodaily.com/pub/uploads/2023/12/Mark-Storey-2-805x1280.png)
Photo taken from Mark Storey/Twitter
Dec 3, 2023, 16:14
Mark Storey: From asymptomatic to oligo, we remain a critical component of treatment
Mark Storey, Radiation Oncologist at the Oklahoma Proton Center, shared on X/Twitter:
“Today’s article looks at radiation in the metastatic setting – Four trials from 2023. Two with OS benefit (while SABR-COMET sits in backdrop). From asymptomatic to oligo, we remain a critical component of treatment.”
Source: Mark Storey/Twitter